The use of stereotactic body radiation therapy in gastrointestinal malignancies in locally advanced and metastatic settings

Clinical Colorectal Cancer

Volumn 9, Issue 3, 2010, Pages 136-143

  Khrizman, Polina ^a   Small, William ^b   Dawson, Laura ^c   Benson III, Al ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Extracranial radiosurgery; Hepatocellular carcinoma; Pancreatic cancer; SBRT

Indexed keywords

ANTINEOPLASTIC AGENT; CA 19-9 ANTIGEN; FLUOROURACIL; GEMCITABINE; YTTRIUM 90;

ADVANCED CANCER; ANOREXIA; BILE DUCT CARCINOMA; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILL; CLINICAL TRIAL; COLON PERFORATION; COLON ULCER; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; EXAMINATION; FEVER; FLUOROSCOPY; FOLLOW UP; GASTRECTOMY; HUMAN; LASER THERMOTHERAPY; LINEAR ACCELERATOR; LIVER CANCER; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER METASTASIS; LIVER RESECTION; LUNG CANCER; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MORTALITY; NAUSEA; NUCLEAR MAGNETIC RESONANCE; OVERALL SURVIVAL; PANCREAS CANCER; PARAAORTIC LYMPH NODE; PATIENT POSITIONING; PLEURA EFFUSION; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIOFREQUENCY ABLATION; RECURRENT DISEASE; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; STOMACH PARESIS; TREATMENT PLANNING; CANCER STAGING; CLINICAL TRIAL (TOPIC); GASTROINTESTINAL NEOPLASMS; METASTASIS; PATHOLOGY; PROCEDURES; RADIOSURGERY;

CLINICAL TRIALS AS TOPIC; GASTROINTESTINAL NEOPLASMS; HUMANS; NEOPLASM METASTASIS; NEOPLASM STAGING; RADIOSURGERY;

EID: 77954971962     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2010.n.018     Document Type: Review

References (69)

1. Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2009. Ca Cancer J Clin 2009; 59:225-249
2. Potters L, Steinberg M, Rose C, et al. American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2004; 60:1026-1032
3. Chang BK, Timmerma RD. Stereotactic body radiation therapy: a comprehensive review. Am J Clin Oncol 2007; 30:637-644
4. Leksell L. The stereotactic method and radiosurgery of the brain. Acta Chir Scand 1951; 102:316-319
5. Kuo JS, Yu C, Petrovich Z, et al. The CyberKnife stereotactic radiosurgery system: description, installation, and an initial evaluation of use and functionality. Neurosurgery 2003; 53:1235-1239
6. Adler JR Jr, Murphy MJ, Chang SD, et al. Image-guided robotic radiosurgery. Neurosurgery 1999; 44:1299-1307
7. Diaz-Santos NC, Blasco Amaro JA, Cardiel GA. The safety and efficacy of robotic image-guided radiosurgery system treatment for intra- and extracranial lesions: a systematic review of the literature. Radiother Oncol 2009; 89:245-253
8. Andrews DW, Bednarz G, Evans JJ, et al. A review of 3 current radiosurgery systems. Surg Neurol 2006; 66:559-564
9. Smythe WR. American College of Chest Physicians. Treatment of stage I non- small-cell lung carcinoma. Chest 2003; 123:181S-7S.
10. Fukumoto S, Shirato H, Shimzu S, et al. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable stage I non-small-cell lung carcinomas. Cancer 2002; 95:1546-1553
11. Hof H, Herfarth K, Munter M, et al. Stereotactic single-dose radiotherapy ofstage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2003; 56:335-341
12. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I non-small-cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multi-institutional study. Cancer 2004; 101:1623-1631
13. Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small-cell lung cancer. Chest 2003; 124:1946-1955
14. Uematsu M, Shioda A, Suda A, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 2001; 51:666-670
15. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24:4833-4839
16. Blomgren H, Lax I, Goranson H, et al. Radiosurgery for tumors in the body: clinical experience using a new method. J Radiosurgery 1998; 1:63-74.
17. Hara R, Itami J, Kondo T, et al. Stereotactic single high dose irradiation of lung tumors under respiratory gating. Radiother Oncol 2002; 63:159-163
18. Lee SW, Choi EK, Park HJ, et al. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer 2003; 40:309-315
19. Nagata Y, Negoro Y, Aoki T, et al. Clinical outcomes of 3D conformal hypofractionated single high dose radiotherapy for one or two lung tumors using stereotactic body frame. Int J Radiat Oncol Biol Phys 2002; 52:1041-1046
20. Nakagawa K, Aoki Y, Tago M, et al. Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: original research in the treatment of thoracic neoplasms. Int J Radiat Oncol Biol Phys 2000; 48:449-457
21. Onimaru R, Shirato H, Shimizu S, et al. Tolerance of organs at risk in small- volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 2003; 56:126-135
22. Uematsu M, Shioda A, Tahara K, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 1998; 82:1062-1070
23. Whyte RI, Crownover R, Murphy MJ, et al. Stereotactic radiosurgery for lung tumors: Preliminary report of a phase I trial. Ann Thora Surg2003; 75:1097-1101
24. Wulf J, Hadinger U, Oppitz U, et al. Stereotactic radiotherapy of targets in lung and liver. Strahlenther Onkol 2001; 177:645-655
25. Wulf J, Haedinger U, Oppitz U, et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004; 60:186-196
26. Rusthoven KE, Kavanagh BD, Burri SH, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009; 27:1579-1584
27. Le QT, Loo BW, Ho A, et al. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol 2006; 1:802-809
28. ClinicalTrials.gov. Available at: http://www.clinicaltrials.gov/ct2/ results?term=SBRT and http://www.clinicaltrials.gov/ct2/results?term=Cyberknife. Accessed: September 1, 2009.
29. Kim MS, Choi CW, Yoo SY, et al. Stereotactic body radiation therapy in patients with pelvic recurrence from rectal carcinoma. Jpn J Clin Oncol 2008; 38:695-700.
30. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235:759-766
31. Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005; 241:715-722
32. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996; 77:1254-1262
33. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230:309-318
34. Wong SL, Mangu PB, Choti MA, et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 2010; 28:493-508.
35. Blomgren H, Lax I, Naslund I, et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator: clinical experience of the first thirty-one patients. Acta Oncol (Madr) 1995; 34:861-870
36. Herfarth KK, Debus J, Lohr F, et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 2001; 19:164-170
37. Hoyer M, Roed H, Hansen AT, et al. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol (Madr) 2006; 45:823-830
38. Kim MS, Yoo SY, Cho CK, et al. Stereotactic body radiation therapy using three fractions for isolated lung recurrence from colorectal cancer. Oncology 2009; 76:212-219
39. Seo DD, Lee HC, Jang MK, et al. Preoperative portal vein embolization and surgical resection in patients with hepatocellular carcinoma and small future liver remnant volume: comparison with transarterial chemoembolization. Ann Surg Oncol 2007; 14:3501-3509
40. Chok KS, Ng KK, Poon RT, et al. Impact of postoperative complications on long- term outcome of curative resection for hepatocellular carcinoma. Br J Surg 2009; 96:81-87
41. Poon RT, Fan ST, Lo CM, et al. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002; 235:373-382
42. Hepatobiliary cancers. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology-v.2.2009. National Comprehensive Cancer Network [Web site]. Available at: http://www.nccn.org/professionals/physician-gls/PDF/ hepatobiliary.pdf. Accessed: September 1, 2009.
43. Choi BO, Choi IB, Jang HS, et al. Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis. BMC Cancer 2008; 8:351.
44. Kianmanesh R, Regimbeau JM, Belghiti J. Selective approach to major hepatic resection for hepatocellular carcinoma in chronic liver disease. Surg Oncol Clin N Am 2003; 12:51-63.
45. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30:1434-1440
46. Tse RV, Hawkins M, Lockwood G, et al. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangio- carcinoma. J Clin Oncol 2008; 26:657-664
47. Yamakado K, Nakatsuka A, Takaki H, et al. Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 2008; 247:260-266
48. Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 1992; 69:925-929
49. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001; 221:159-166
50. Vogl TJ, Straub R, Eichler K, et al. Colorectal carcinoma metastases in liver: laser- induced interstitial thermotherapy-local tumor control rate and survival data. Radiology 2004; 230:450-458 (Pubitemid 38133806)
51. Wulf J, Guckenberger M, Haedinger U, et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol (Madr) 2006; 45:838-847
52. Timmerman RD, Bizekis CS, Pass HI, et al. Local surgical, ablative, and radiation treatment of metastases. CA Cancer J Clin 2009; 59:145-170
53. Chang BW, SaifMW. Stereotactic body radiation therapy (SBRT) in pancreatic cancer: is it ready for prime time? JOP 2008; 9:676-682
54. Moertel CG, Frytak S, Hahn RG, et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation+5=fluorouracil: the Gastrointestinal Tumor Study Group. Cancer 1981; 48:1705-1710
55. Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 1988; 80:751-755
56. Koong AC, Le QT, Ho A, et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2004; 58:1017-1021
57. Hoyer M, Roed H, Sengleov L, et al. Phase II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol 2005; 76:48-53.
58. Koong AC, Christofferson E, Le QT, et al. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2005; 63:320-323
59. Haddock MG, Swaminathan R, Foster NR, et al. Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group phase II study N9942. J Clin Oncol 2007; 25:2567-2572
60. Shibuya K, Oya N, Fujii T, et al. Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer. Am J Clin Oncol 2010. [Epub ahead of print]
61. Crane CH, Winter K, Regine WF, et al. Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411. J Clin Oncol 2009; 27:4096-4102
62. Small W Jr, Berlin J, Freedman GM, et al. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. J Clin Oncol 2008; 26:942-947
63. Schellenberg D, Goodman KA, Lee F, et al. Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2008; 72:678-686
64. Ben-Josef E, Griffith K, Francis IR, et al. Phase I radiation dose escalation trial of intensity-modulated radiotherapy (IMRT) with concurrent fixed dose-rate gemcitabine (FDR-G) for unresectable pancreatic cancer. J Clin Oncol 2009; 27(15 suppl):226s (abstract 4602).
65. Mahadevan A, Shanmugam L, Kaplan I, et al. Fractionated radiosurgery for pancreas cancer. Int J Radiat Oncol Biol Phys 2007; 69:S307.
66. Parikh SD, Burton SA, Heron DE, et al. Stereotactic radiosurgery in patients with resected pancreatic carcinomas with positive margins. Int J Radiat Oncol Biol Phys 2008; 72(suppl):S272-3.
67. Lominska CE, Nasr NM, Silver NL, et al. Salvage stereotactic radiosurgery for locally recurrent previously irradiated pancreatic cancer. Int j Radiat Oncol Biol Phys 2008; 72(1 suppl):S276
68. Kim MS, Yoo SY, Cho CK, et al. Stereotactic body radiotherapy for isolated paraaortic lymph node recurrence after curative resection in gastric cancer. J Korean Med Sci 2009; 24:488-492
69. Hama Y, Uematsu M, Shioda A, et al. Severe complications after hypofractionated high dose rate intracavitary brachytherapy following external beam irradiation for esophageal carcinoma. Br J Radiol 2002; 75:238-242.